Back

Fisher information matrix computation for joint longitudinal and survival models to support clinical study design and covariate effect assessment

Fayette, L.; Brendel, K.; Mentre, F.

2026-06-01 pharmacology and therapeutics
10.64898/2026.05.28.26354340 medRxiv
Show abstract

Joint modelling of longitudinal data using non-linear mixed effects models and time-to-event outcomes provides a suitable framework to account for informative censoring when estimating biomarker dynamics and quantifying event risk using covariates and longitudinal trajectories. Their usefulness in clinical research depends on data collection design, particularly to precisely estimate the association (link) parameter between longitudinal and survival processes. However, optimal design strategies have so far been addressed separately for longitudinal and survival endpoints and remain unexplored for joint models. We propose two Fisher Information Matrix (FIM) computation methods for joint models, relying on Monte-Carlo integration over observations combined with either Markov Chains Monte-Carlo or Adaptive Gaussian Quadrature to integrate random effects. Their accuracy is assessed against clinical trial simulations in an oncological example based on the HORIZON III study with a tumour-growth-survival model including discrete and continuous covariates. We apply these methods to quantify the impact of follow-up duration, sampling richness, sample size, and covariate distribution on parameter uncertainty and test power. In our example, longitudinal-parameter uncertainty is barely affected by follow-up duration or sampling richness, whereas survival-parameter uncertainty decreases substantially from 1-year to 2-year follow-up. The number of subjects needed (NSN) to achieve <15\% uncertainty on the link parameter is comparable for a 2-year rich design and a 3-year sparse design. Optimal covariate distributions are stable across designs and systematically improve test power, outperforming longer and richer but non-optimised designs. These FIM-based methods accurately predict uncertainty and test powers, enabling design evaluation and NSN computation for joint-model-based clinical studies.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Statistics in Medicine
34 papers in training set
Top 0.1%
7.0%
2
Nature Communications
4913 papers in training set
Top 28%
6.5%
3
The American Journal of Human Genetics
206 papers in training set
Top 0.7%
6.5%
4
Scientific Reports
3102 papers in training set
Top 15%
6.5%
5
PLOS ONE
4510 papers in training set
Top 26%
6.5%
6
NeuroImage
813 papers in training set
Top 2%
6.5%
7
eLife
5422 papers in training set
Top 16%
5.0%
8
npj Systems Biology and Applications
99 papers in training set
Top 0.3%
4.4%
9
Computational and Structural Biotechnology Journal
216 papers in training set
Top 1%
4.1%
50% of probability mass above
10
Human Brain Mapping
295 papers in training set
Top 2%
3.7%
11
PLOS Computational Biology
1633 papers in training set
Top 11%
2.8%
12
Clinical and Translational Science
21 papers in training set
Top 0.3%
2.1%
13
Patterns
70 papers in training set
Top 0.5%
2.1%
14
NeuroImage: Clinical
132 papers in training set
Top 2%
1.9%
15
Biometrics
22 papers in training set
Top 0.1%
1.9%
16
Journal of Biomedical Informatics
45 papers in training set
Top 0.7%
1.9%
17
Bioinformatics
1061 papers in training set
Top 7%
1.7%
18
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 0.4%
1.4%
19
Briefings in Bioinformatics
326 papers in training set
Top 5%
1.3%
20
npj Genomic Medicine
33 papers in training set
Top 0.5%
1.3%
21
BioData Mining
15 papers in training set
Top 0.5%
1.1%
22
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.1%
23
Communications Biology
886 papers in training set
Top 18%
0.9%
24
BMC Bioinformatics
383 papers in training set
Top 6%
0.9%
25
Clinical Cancer Research
58 papers in training set
Top 2%
0.8%
26
Cell Systems
167 papers in training set
Top 12%
0.8%
27
Computer Methods and Programs in Biomedicine
27 papers in training set
Top 1%
0.7%
28
Cancer Cell
38 papers in training set
Top 2%
0.5%
29
Nature Methods
336 papers in training set
Top 7%
0.5%
30
Proceedings of the Royal Society B: Biological Sciences
341 papers in training set
Top 8%
0.5%